Skip to content

TOX-MISSION

Assessment of Complications from Auto-Intoxications during Hospital Admissions - Assessment of Complications from Auto-Intoxications during Hospital Admissions

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON61522
Enrollment
3
Registered
2026-06-25
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

auto-intoxication, complications overdose

Interventions

Sponsors

Albert Schweitzer Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older Auto-intoxication with pharmaceutical medication and/or drugs 

Exclusion criteria

Exclusion criteria: Younger than 18 years Auto-intoxication involving alcohol exclusively Auto-intoxication due to an unknown substance 

Design outcomes

Primary

MeasureTime frame
The primary endpoint is to characterize complications occurring in hospitalized patients with acute auto-intoxications and to describe the medical interventions required. Complications will be categorized according to type and severity and analyzed in relation to the substance(s) involved. The following variables will be evaluated: type and severity of complication, the time interval between substance ingestion and the onset of complication(s), the primary reason for admission the type of hospital ward to which the patient was admitted. The association between intoxication category and complication type will be investigated. Potential determinants of complication: type and severity will also be explored, including; substance category, sex, age, psychiatric history and if the intoxication was deliberate or accidental. 

Secondary

MeasureTime frame
Secondary outcomes include the frequency of consultation with a hospital pharmacist and/or poison control center, the association between such consultations and complication rates, length of hospital stay and reasons for deviations from the recommended observation period.  

Countries

Netherlands

Contacts

Public ContactS Schol-Gelok

Albert Schweitzer Ziekenhuis

s.gelok@asz.nl0786541050

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Sep 19, 2026